Literature DB >> 24853805

An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium.

Romain Parent1, David Durantel1, Thomas Lahlali2, Aurélie Sallé2, Marie-Laure Plissonnier2, Daniel DaCosta2, Gaëtan Lesca3, Fabien Zoulim4, Marie-Jeanne Marion2, Birke Bartosch5.   

Abstract

BACKGROUND: The endothelium lines blood and lymph vessels and protects underlying tissues against external agents such as viruses, bacteria and parasites. Yet, microbes and particularly viruses have developed sophisticated ways to bypass the endothelium in order to gain access to inner organs. De novo infection of the liver parenchyma by many viruses and notably hepatitis viruses, is thought to occur through recruitment of virions on the sinusoidal endothelial surface and subsequent transfer to the epithelium. Furthermore, the liver endothelium undergoes profound changes with age and in inflammation or infection. However, primary human liver sinusoidal endothelial cells (LSECs) are difficult to obtain due to scarcity of liver resections. Relevant derived cell lines are needed in order to analyze in a standardized fashion the transfer of pathogens across the liver endothelium. By lentiviral transduction with hTERT only, we have immortalized human LSECs isolated from a hereditary hemorrhagic telangiectasia (HHT) patient and established the non-transformed cell line TRP3. TRP3 express mesenchymal, endothelial and liver sinusoidal markers. Functional assessment of TRP3 cells demonstrated a high capacity of endocytosis, tube formation and reactivity to immune stimulation. However, TRP3 displayed few fenestrae and expressed C-type lectins intracellularly. All these findings were confirmed in the original primary LSECs from which TRP3 were derived suggesting that these features were already present in the liver donor. We consider TRP3 as a model to investigate the functionality of the liver endothelium in hepatic inflammation in infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adhesion molecules; Differentiation; Inflammation; Liver sinusoidal endothelial cells; Tubulogenesis; Uptake

Mesh:

Year:  2014        PMID: 24853805     DOI: 10.1016/j.bbrc.2014.05.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms.

Authors:  A S Khazali; A M Clark; A Wells
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

Review 2.  Progress and challenges in the development of a cell-based therapy for hemophilia A.

Authors:  M E Fomin; P P Togarrati; M O Muench
Journal:  J Thromb Haemost       Date:  2014-10-31       Impact factor: 5.824

Review 3.  Human biomimetic liver microphysiology systems in drug development and precision medicine.

Authors:  Albert Gough; Alejandro Soto-Gutierrez; Lawrence Vernetti; Mo R Ebrahimkhani; Andrew M Stern; D Lansing Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-17       Impact factor: 73.082

4.  Immortalization of Porcine 11β-Hydroxysteroid Dehydrogenase Type 1-Transgenic Liver Cells Using SV40 Large T Antigen.

Authors:  Hee Young Kang; Young-Kwon Choi; Yeon Ik Jeong; Kyung-Chul Choi; Sang-Hwan Hyun; Woo-Suk Hwang; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

Review 5.  Pathological process of liver sinusoidal endothelial cells in liver diseases.

Authors:  Yao Ni; Juan-Mei Li; Ming-Kun Liu; Ting-Ting Zhang; Dong-Ping Wang; Wen-Hui Zhou; Ling-Zi Hu; Wen-Liang Lv
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

6.  Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells.

Authors:  Aldy Aliyandi; Catharina Reker-Smit; Reinier Bron; Inge S Zuhorn; Anna Salvati
Journal:  ACS Biomater Sci Eng       Date:  2021-11-11

Review 7.  Bioengineering considerations in liver regenerative medicine.

Authors:  Ogechi Ogoke; Janet Oluwole; Natesh Parashurama
Journal:  J Biol Eng       Date:  2017-11-26       Impact factor: 4.355

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.